Month: May 2020

TAMPA, Fla., May 04, 2020 (GLOBE NEWSWIRE) — Sykes Enterprises, Incorporated (“SYKES” or the “Company”) (NASDAQ: SYKE), a leading full life cycle provider of global customer engagement services, multichannel demand generation and digital transformation, has released its financial results for the first-quarter ended March 31, 2020. The first-quarter 2020 financial results can be viewed at either www.sykes.com, under the “Investor News” section, or using the following link: http://investor.sykes.com/company/investors/investor-news/default.aspx.Forward-Looking StatementsThis press release may contain “forward-looking statements,” including SYKES’ estimates of its future business outlook, prospects or financial results. Statements regarding SYKES’ objectives, expectations, intentions, beliefs or strategies, or statements containing...

DUBLIN, Ireland, May 04, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 11, 2020, to provide a corporate update and discuss the Company’s financial results for the first quarter ended March 31, 2020.To access the conference call, investors are invited to dial 877-407-9716 (U.S. and Canada) or 201-493-6779 (international). The conference ID number is 13703221. A live audio webcast can be accessed by visiting the investor relations section of the Company’s website, www.avadel.com. A replay of the webcast will be archived on...

Annual recurring revenues of $220.5 million, representing growth of 59% over Q1 2019Subscription revenues mix of 98%, compared to 31% in Q1 2019NEW YORK, May 04, 2020 (GLOBE NEWSWIRE) — Varonis Systems, Inc. (Nasdaq: VRNS), a pioneer in data security and analytics, today announced results for the first quarter ended March 31, 2020.“We are operating in unprecedented times, requiring us to plan carefully, act decisively and remain nimble, the same skills that we used to successfully transition Varonis to a subscription model over the last year,” said Yaki Faitelson, Varonis CEO. “The disruption that COVID-19 has caused to businesses globally is undeniable. However, at the same time the associated risks to our customers – specifically, the confluence of a distributed workforce, the elevated use of VPNs and unsecured...

DALLAS and FORT WORTH, Texas, May 04, 2020 (GLOBE NEWSWIRE) — Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that it will report its first quarter 2020 financial results at the closing of U.S. financial markets on Monday, May 11, 2020. Neos management will host a conference call and live audio webcast to discuss these results and provide a company update at 5:00 p.m. ET that same day.The live call may be accessed by dialing (877) 388-8985 for domestic calls, or +1 (562) 912-2654 for international callers, and referencing conference ID number 1099917. A live audio webcast for the conference call will be available on the Investor Relations page of the company’s website at http://investors.neostx.com/ and will be...

BOULDER, Colo., May 04, 2020 (GLOBE NEWSWIRE) — Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that it will report its first quarter 2020 financial results after the close of the U.S. financial markets on Wednesday, May 13, 2020. Brickell’s management will host a conference call at 4:30 p.m. ET to discuss the financial results and recent corporate highlights.The dial-in number for the conference call is 1-855-327-6837 for domestic participants and 1-631-891-4304 for international participants, with Conference ID #10009475.  A live webcast of the conference call can be accessed through the “Investors” tab on the Brickell Biotech website at http://www.brickellbio.com/. ...

SANTA CLARA, Calif., May 04, 2020 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2020.Recent HighlightsRevenue of $16.8 million for the first quarter 2020, representing a 12% increase over the corresponding period in 2019U.S. revenue of $15.3 million for the first quarter 2020, representing a 14% increase over the corresponding period in 2019Received FDA 510(k) clearance for an expanded indication for the iFuse Implant System to support the Company’s trauma programObtained positive coverage by Health Alliance Plan, a commercial payor in Michigan“Our SI-BONE team has shown tremendous efforts and strength through these difficult times. I am incredibly proud to be...

First Quarter 2020 Results:Revenue totals $7.8 million, growing 44% year over yearBillable tests delivered total 13,163, growing 75% year over yearGross Margin improves approximately 3 percentage points year over year; cost per test improves approximately 22% year over yearGAAP loss of $2.0 million, or $0.09 per shareNon-GAAP loss of $749,000, or $0.03 per shareAdjusted EBITDA loss of $506,000TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020.First quarter revenue was $7.8 million, an increase of 44% year over year from $5.4 million in the first quarter of 2019. GAAP loss...

HAUPPAUGE, N.Y., May 04, 2020 (GLOBE NEWSWIRE) — Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care diagnostic company focused on infectious diseases, today announced it has attained the CE Marking for its DPP COVID-19 System. The CE Marking represents the ability to commercialize the system within the member states of the European Union and the Caribbean region, except for Puerto Rico.“The CE Marking is another significant accomplishment for Chembio and expands the market opportunity for our DPP COVID-19 rapid serological test meaningfully,” stated Rick Eberly, Chembio’s Chief Executive Officer. “We are pleased to begin commercializing and continuing to support the decentralization that is needed to address the ongoing demand for testing. We believe our platform will add tremendous value in determining the IgM and...

LOUISVILLE, Ky., May 04, 2020 (GLOBE NEWSWIRE) — Texas Roadhouse, Inc. (NasdaqGS: TXRH), today provided a statement from Kent Taylor, Founder of Texas Roadhouse, announced financial results for the 13 week period ended March 31, 2020 and provided a business update in response to the COVID-19 pandemic.Founder LetterHello Roadies, Shareholders, Loyal Guests, and Interested Folks,As everyone’s world has obviously changed, so has ours.  I still remember the early days of Texas Roadhouse back in the mid-1990’s, when three of our first five stores failed. Survival mode was where I lived for quite a few years.  Well, damn, if I didn’t find myself right back there again.  Five restaurants have become 600 and 400 employees have become 75,000+.  Back then in my mid-30’s, our Roadies were close to my age, and I thought of our company as a...